4'-O-tetrahydropyranyl-doxorubicin in advanced breast cancer: a phase II study.
Samonigg H, Kasparek AK, Stöger H, Schmid M, Eber B, Stark G, Weinrauch V, Pfeiffer K, Smola M, Steindorfer P, et al.
Samonigg H, et al. Among authors: stoger h.
Cancer Chemother Pharmacol. 1990;26(4):293-6. doi: 10.1007/BF02897233.
Cancer Chemother Pharmacol. 1990.
PMID: 2369794